T80.82
Complication of immune effector cellular therapy
- Release
- FY 2027
- Effective
Hierarchy
Where T80.82 sits in the official hierarchy. Each level is the code it is classified under.
- T80 Complications following infusion, transfusion and therapeutic injection
- T80.8 Parent Other complications following infusion, transfusion and therapeutic injection
- T80.82 This code Complication of immune effector cellular therapy
Official Coding Notes
Reproduced verbatim from the FY 2027 ICD-10-CM files. Notes labelled as inherited are declared on a parent code and apply here too.
Includes
complications following perfusion
Inherited from T80 — Complications following infusion, transfusion and therapeutic injection
Inclusion Terms
Complication of chimeric antigen receptor (CAR-T) cell therapy
Inclusion Terms
Complication of IEC therapy
Excludes2
bone marrow transplant rejection ( T86.01 )
Inherited from T80 — Complications following infusion, transfusion and therapeutic injection
Excludes2
adverse effect of immune checkpoint inhibitors and immunostimulant drugs ( T45.AX5 )
Excludes2
febrile nonhemolytic transfusion reaction ( R50.84 )
Inherited from T80 — Complications following infusion, transfusion and therapeutic injection
Excludes2
complication of bone marrow transplant ( T86.0 )
Excludes2
fluid overload due to transfusion ( E87.71 )
Inherited from T80 — Complications following infusion, transfusion and therapeutic injection
Excludes2
complication of stem cell transplant ( T86.5 )
Excludes2
posttransfusion purpura ( D69.51 )
Inherited from T80 — Complications following infusion, transfusion and therapeutic injection
Excludes2
transfusion associated circulatory overload (TACO) ( E87.71 )
Inherited from T80 — Complications following infusion, transfusion and therapeutic injection
Use Additional Code
code to identify the specific complication, such as:
Use Additional Code
cytokine release syndrome ( D89.83- )
Use Additional Code
immune effector cell-associated neurotoxicity syndrome ( G92.0- )
7th Character
The appropriate 7th character is to be added to each code from category T80
Inherited from T80 — Complications following infusion, transfusion and therapeutic injection
7th Character
A - initial encounter
Inherited from T80 — Complications following infusion, transfusion and therapeutic injection
7th Character
D - subsequent encounter
Inherited from T80 — Complications following infusion, transfusion and therapeutic injection
7th Character
S - sequela
Inherited from T80 — Complications following infusion, transfusion and therapeutic injection
More Specific Codes
3 codes under T80.82
Version History
How T80.82 appears in each release imported from the official files, newest first.
-
FY 2027 Effective
CurrentComplication of immune effector cellular therapy
-
FY 2026 Effective
UnchangedComplication of immune effector cellular therapy
Related Codes
Other codes under T80.8
Codes whose official notes reference T80.82
Data Source
Code information on this page is derived from the FY 2027 ICD-10-CM files published by CDC NCHS and CMS.
- Release
- FY 2027
- Effective
- Source file
- icd10cm-code-descriptions-2027.zip
Official ICD-10-CM source files (opens in a new tab)
MedCodeSearch is an independent reference service and is not affiliated with CMS, CDC, or the U.S. government.
Look up another code
Search ICD-10-CM, ICD-10-PCS and HCPCS Level II by code or description.